Featuring Matthew Feeney, Policy Analyst, Cato Institute; Marc Scribner, Research Fellow, Competitive Enterprise Institute; and Dean Baker, Co-Director, Center for Economic and Policy Research; moderated by Brink Lindsey, Vice President for Research, Cato Institute.
Obesity remains a serious health problem and it is no secret that many people want to lose weight. Behavioral economists typically argue that “nudges” help individuals with various decisionmaking flaws to live longer, healthier, and better lives. In an article in the new issue of Regulation, Michael L. Marlow discusses how nudging by government differs from nudging by markets, and explains why market nudging is the more promising avenue for helping citizens to lose weight.
Two long wars, chronic deficits, the financial crisis, the costly drug war, the growth of executive power under Presidents Bush and Obama, and the revelations about NSA abuses, have given rise to a growing libertarian movement in our country – with a greater focus on individual liberty and less government power. David Boaz’s newly released The Libertarian Mind is a comprehensive guide to the history, philosophy, and growth of the libertarian movement, with incisive analyses of today’s most pressing issues and policies.
Featuring Lorens Helmchen, Associate Professor of Health Administration and Policy, George Mason University; Mark V. Pauly, Bendheim Professor, Professor of Health Care Management, The Wharton School, University of Pennsylvania; moderated by Michael F. Cannon, Director of Health Policy Studies, Cato Institute.
Can Medicare vouchers, such as the proposal authored by House Budget Committee chairman Paul Ryan (R-WI) that has passed the House of Representatives, restrain Medicare spending without harming the health of enrollees? Health economist Lorens Helmchen suggests that cash payments to patients, either through a lump sum or negative co-payments, could allow Medicare to “spend less by paying more.” Health care experts will discuss the benefits and difficulties of such payments, particularly how they affect Medicare spending, patient choice, incentives for cost-effective treatment, and medical innovation.